Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicholas John Kramer, Ph.D.

Concepts

This page shows the publications Nicholas Kramer has written about Mice.
Connection Strength

0.093
  1. CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat Genet. 2018 04; 50(4):603-612.
    View in: PubMed
    Score: 0.028
  2. Altered lymphopoiesis and immunodeficiency in miR-142 null mice. Blood. 2015 Jun 11; 125(24):3720-30.
    View in: PubMed
    Score: 0.023
  3. A versatile system to record cell-cell interactions. Elife. 2020 10 07; 9.
    View in: PubMed
    Score: 0.008
  4. The exploration of aza-quinolines as hematopoietic prostaglandin D synthase (H-PGDS) inhibitors with low brain exposure. Bioorg Med Chem. 2020 12 01; 28(23):115791.
    View in: PubMed
    Score: 0.008
  5. Toxic expanded GGGGCC repeat transcription is mediated by the PAF1 complex in C9orf72-associated FTD. Nat Neurosci. 2019 06; 22(6):863-874.
    View in: PubMed
    Score: 0.008
  6. LRRK2 modifies a-syn pathology and spread in mouse models and human neurons. Acta Neuropathol. 2019 06; 137(6):961-980.
    View in: PubMed
    Score: 0.007
  7. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat Neurosci. 2015 Sep; 18(9):1226-9.
    View in: PubMed
    Score: 0.006
  8. Parkinson's disease genes VPS35 and EIF4G1 interact genetically and converge on a-synuclein. Neuron. 2015 Jan 07; 85(1):76-87.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.